New Eczema Drug Promising in Early Trial
THURSDAY, March 2, 2017 -- An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds.
Nemolizumab is a man-made, injectable antibody that acts against the...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news
More News: Eczema | General Medicine